Annual Accounts Receivable
$16.64 M
-$1.65 M-9.04%
April 30, 2024
Summary
- As of February 8, 2025, CDMO annual accounts receivable is $16.64 million, with the most recent change of -$1.65 million (-9.04%) on April 30, 2024.
- During the last 3 years, CDMO annual accounts receivable has fallen by -$2.20 million (-11.67%).
- CDMO annual accounts receivable is now -19.00% below its all-time high of $20.55 million, reached on April 30, 2022.
Performance
CDMO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$18.41 M
-$2.55 M-12.17%
October 31, 2024
Summary
- As of February 8, 2025, CDMO quarterly accounts receivable is $18.41 million, with the most recent change of -$2.55 million (-12.17%) on October 31, 2024.
- Over the past year, CDMO quarterly accounts receivable has dropped by -$2.55 million (-12.17%).
- CDMO quarterly accounts receivable is now -34.27% below its all-time high of $28.01 million, reached on January 31, 2022.
Performance
CDMO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CDMO Accounts Receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -9.0% | -12.2% |
3 y3 years | -11.7% | -10.4% |
5 y5 years | +125.7% | -10.4% |
CDMO Accounts Receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -19.0% | at low | -34.3% | +37.6% |
5 y | 5-year | -19.0% | +125.7% | -34.3% | +113.9% |
alltime | all time | -19.0% | >+9999.0% | -34.3% | >+9999.0% |
Avid Bioservices Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Oct 2024 | - | $18.41 M(-12.2%) |
Jul 2024 | - | $20.96 M(+25.9%) |
Apr 2024 | $16.64 M(-9.0%) | $16.64 M(-10.2%) |
Jan 2024 | - | $18.54 M(+38.6%) |
Oct 2023 | - | $13.38 M(-17.5%) |
Jul 2023 | - | $16.21 M(-11.4%) |
Apr 2023 | $18.30 M(-10.9%) | $18.30 M(+23.4%) |
Jan 2023 | - | $14.83 M(-28.0%) |
Oct 2022 | - | $20.58 M(-20.7%) |
Jul 2022 | - | $25.95 M(+26.3%) |
Apr 2022 | $20.55 M(+9.0%) | $20.55 M(-26.6%) |
Jan 2022 | - | $28.01 M(+54.4%) |
Oct 2021 | - | $18.14 M(-1.2%) |
Jul 2021 | - | $18.35 M(-2.6%) |
Apr 2021 | $18.84 M(+118.9%) | $18.84 M(-30.5%) |
Jan 2021 | - | $27.11 M(+134.4%) |
Oct 2020 | - | $11.57 M(-19.2%) |
Jul 2020 | - | $14.31 M(+66.3%) |
Apr 2020 | $8.61 M(+16.7%) | $8.61 M(-15.2%) |
Jan 2020 | - | $10.15 M(+36.8%) |
Oct 2019 | - | $7.42 M(-9.7%) |
Jul 2019 | - | $8.22 M(+11.5%) |
Apr 2019 | $7.37 M(+108.4%) | $7.37 M(-6.5%) |
Jan 2019 | - | $7.88 M(+88.5%) |
Oct 2018 | - | $4.18 M(+47.6%) |
Jul 2018 | - | $2.83 M(-19.9%) |
Apr 2018 | $3.54 M(-51.3%) | $3.54 M(-55.6%) |
Jan 2018 | - | $7.97 M(+131.7%) |
Oct 2017 | - | $3.44 M(-36.9%) |
Jul 2017 | - | $5.45 M(-25.0%) |
Apr 2017 | $7.27 M(+191.7%) | $7.27 M(+28.9%) |
Jan 2017 | - | $5.64 M(+1.7%) |
Oct 2016 | - | $5.55 M(-22.6%) |
Jul 2016 | - | $7.17 M(+187.4%) |
Apr 2016 | $2.49 M(-27.1%) | $2.49 M(-69.7%) |
Jan 2016 | - | $8.23 M(+227.1%) |
Oct 2015 | - | $2.52 M(+77.6%) |
Jul 2015 | - | $1.42 M(-58.6%) |
Apr 2015 | $3.42 M(+180.8%) | $3.42 M(-38.6%) |
Jan 2015 | - | $5.57 M(+69.4%) |
Oct 2014 | - | $3.29 M(+148.4%) |
Jul 2014 | - | $1.32 M(+8.6%) |
Apr 2014 | $1.22 M(-25.8%) | $1.22 M(-56.0%) |
Jan 2014 | - | $2.77 M(+43.4%) |
Oct 2013 | - | $1.93 M(+16.0%) |
Jul 2013 | - | $1.66 M(+1.3%) |
Apr 2013 | $1.64 M | $1.64 M(-16.4%) |
Date | Annual | Quarterly |
---|---|---|
Jan 2013 | - | $1.96 M(-15.1%) |
Oct 2012 | - | $2.31 M(+4.1%) |
Jul 2012 | - | $2.22 M(-1.9%) |
Apr 2012 | $2.26 M(+63.0%) | $2.26 M(+9.0%) |
Jan 2012 | - | $2.08 M(+74.5%) |
Oct 2011 | - | $1.19 M(+9.6%) |
Jul 2011 | - | $1.09 M(-21.7%) |
Apr 2011 | $1.39 M(-6.2%) | $1.39 M(-44.9%) |
Oct 2010 | - | $2.52 M(+70.3%) |
Apr 2010 | $1.48 M(-16.3%) | $1.48 M(-13.6%) |
Jul 2009 | - | $1.72 M(-3.1%) |
Apr 2009 | $1.77 M(+192.6%) | $1.77 M(-11.1%) |
Jan 2009 | - | $1.99 M(+13.9%) |
Oct 2008 | - | $1.75 M(-16.8%) |
Jul 2008 | - | $2.10 M(+246.9%) |
Apr 2008 | $605.00 K(-19.3%) | $605.00 K(-54.0%) |
Jan 2008 | - | $1.32 M(+27.9%) |
Oct 2007 | - | $1.03 M(-32.0%) |
Jul 2007 | - | $1.51 M(+101.9%) |
Apr 2007 | $750.00 K(+29.5%) | $750.00 K(-21.6%) |
Jan 2007 | - | $957.00 K(+19.5%) |
Oct 2006 | - | $801.00 K(+205.7%) |
Jul 2006 | - | $262.00 K(-54.7%) |
Apr 2006 | $579.00 K(+19.1%) | $579.00 K(-15.0%) |
Jan 2006 | - | $681.00 K(+38.7%) |
Oct 2005 | - | $491.00 K(+21.2%) |
Jul 2005 | - | $405.00 K(-16.7%) |
Apr 2005 | $486.00 K(-68.0%) | $486.00 K(-5.4%) |
Jan 2005 | - | $514.00 K(-34.2%) |
Oct 2004 | - | $781.00 K(-35.8%) |
Jul 2004 | - | $1.22 M(-20.0%) |
Apr 2004 | $1.52 M(+520.4%) | $1.52 M(+5.3%) |
Jan 2004 | - | $1.44 M(+285.8%) |
Oct 2003 | - | $374.00 K(+43.8%) |
Jul 2003 | - | $260.00 K(+6.1%) |
Apr 2003 | $245.00 K(-25.3%) | $245.00 K(-78.7%) |
Jan 2003 | - | $1.15 M(+60.1%) |
Oct 2002 | - | $717.00 K(+16.2%) |
Jul 2002 | - | $617.00 K(+88.1%) |
Apr 2002 | $328.00 K(+613.0%) | $328.00 K(+1829.4%) |
Jan 2002 | - | $17.00 K(-39.3%) |
Oct 2001 | - | $28.00 K(-12.5%) |
Jul 2001 | - | $32.00 K(-30.4%) |
Apr 2001 | $46.00 K(-48.9%) | $46.00 K(-48.9%) |
Apr 2000 | $90.00 K(-10.0%) | $90.00 K(-10.0%) |
Apr 1996 | $100.00 K(-50.0%) | $100.00 K(-50.0%) |
Apr 1995 | $200.00 K | $200.00 K |
FAQ
- What is Avid Bioservices annual accounts receivable?
- What is the all time high annual accounts receivable for Avid Bioservices?
- What is Avid Bioservices annual accounts receivable year-on-year change?
- What is Avid Bioservices quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Avid Bioservices?
- What is Avid Bioservices quarterly accounts receivable year-on-year change?
What is Avid Bioservices annual accounts receivable?
The current annual accounts receivable of CDMO is $16.64 M
What is the all time high annual accounts receivable for Avid Bioservices?
Avid Bioservices all-time high annual accounts receivable is $20.55 M
What is Avid Bioservices annual accounts receivable year-on-year change?
Over the past year, CDMO annual accounts receivable has changed by -$1.65 M (-9.04%)
What is Avid Bioservices quarterly accounts receivable?
The current quarterly accounts receivable of CDMO is $18.41 M
What is the all time high quarterly accounts receivable for Avid Bioservices?
Avid Bioservices all-time high quarterly accounts receivable is $28.01 M
What is Avid Bioservices quarterly accounts receivable year-on-year change?
Over the past year, CDMO quarterly accounts receivable has changed by -$2.55 M (-12.17%)